Skip to Content

Join the 'Breast Cancer - Palliative' group to help and get support from people like you.

Breast Cancer - Palliative News

More Hispanics Treated at Breast Cancer Center After Obamacare

Posted 14 hours ago by Drugs.com

SUNDAY, Sept. 25, 2016 – After the Affordable Care Act (ACA) was implemented in 2014, more Hispanic women received breast cancer treatment and enrolled in clinical trials at a California cancer center, a new study finds. "Our study shows that with the implementation of the ACA in California, our cancer center's Hispanic breast cancer patient population increased significantly," Chloe Lalonde said in a news release from the American Association for Cancer Research. "We also observed an increase in the proportion of Hispanic women who consented to be part of a national clinical trial, including a substantial increase in Spanish-speaking patients," Lalonde said. She was a clinical research coordinator at the University of California, San Diego, Moores Cancer Center during the study. The researchers suspect the increase was from previously uninsured patients getting insurance under the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative

More Breast Cancer Patients Should Get Radiation, New Guidelines Say

Posted 5 days ago by Drugs.com

WEDNESDAY, Sept. 21, 2016 – New guidelines issued by three leading cancer organizations suggest that more breast cancer patients should get radiation therapy after a mastectomy. Overall, the guidelines say there's enough evidence to show radiation treatment after a mastectomy decreases the risk of breast cancer recurrence, and that even women with smaller tumors and three or fewer lymph nodes involved can benefit from the therapy. "The new guidelines say there is clear evidence that the benefit of [post-mastectomy radiation therapy] extends to women with limited lymph node involvement," said Dr. Stephen Edge. He is vice president for health care outcomes and policy at Roswell Park Cancer Institute in Buffalo, N.Y. Edge was co-chair of the panel that developed the new guidelines. One radiation treatment expert welcomed the updated recommendations. "The guideline is timely," said Dr. ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Palliative, History - Radiation Therapy

Early Palliative Care Improves Patients' Quality of Life

Posted 17 days ago by Drugs.com

FRIDAY, Sept. 9, 2016 – Starting palliative care shortly after a person is diagnosed with incurable cancer helps patients cope and improves their quality of life, a new study shows. It also leads to more discussions about patients' end-of-life care preferences, the researchers added. Palliative care, also called comfort care, is given to improve the quality of life for patients who have a life-threatening disease or terminal illness, such as cancer. The goal is not to cure the patient, but to manage the symptoms of the disease, according to the U.S. National Cancer Institute. The new study included 350 people recently diagnosed with incurable lung or gastrointestinal cancer. They were randomly assigned to one of two care groups. One group received early palliative care integrated with cancer care. The other received cancer care alone. The patients were evaluated at 12 and 24 weeks ... Read more

Related support groups: Cancer, Breast Cancer - Palliative

Two Genes Might Help Predict Breast Cancer Survival

Posted 18 Aug 2016 by Drugs.com

THURSDAY, Aug. 18, 2016 – The activity of two genes may help predict certain breast cancer patients' chances of survival and guide their treatment, British researchers report. "We have seen major strides in the treatment of breast cancer, but once it begins to spread round the body it is still often fatal," said Paul Workman. He is chief executive of the Institute of Cancer Research (ICR) in London, which conducted the research. "This new study helps us understand some of the processes that control how breast cancers spread, and identifies a pattern of genetic activity that could be used to pick out women particularly at risk," Workman said in an institute news release. In the study, a team led by ICR researcher Paul Huang looked at tumors from nearly 2,000 breast cancer patients. They focused on HER-2 positive breast cancers, which account for about 20 percent of breast cancers. ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation

New Guidelines Set Safe Surgery Margins for Some Breast Cancers

Posted 15 Aug 2016 by Drugs.com

FRIDAY, Aug. 12, 2016 – New surgery guidelines for certain breast cancer patients could reduce both unnecessary surgeries and recurrence rates, three U.S. cancer groups say. The guideline is for treatment of women with ductal carcinoma in situ (DCIS) who undergo breast-conserving surgery with whole breast radiation. DCIS is an early stage cancer. "The use of a 2-millimeter margin as the standard for an adequate margin in DCIS treated with whole breast radiation therapy is associated with low rates of recurrence of cancer in the breast and has the potential to decrease re-excision rates, improve cosmetic outcome and decrease health care costs," according to the guideline from the Society of Surgical Oncology, the American Society for Radiation Oncology and the American Society of Clinical Oncology. "Margins more widely clear than 2 millimeters do not further reduce the rates of ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Cardiothoracic Surgery

Insurance, Distance Often Prevent Breast Reconstruction After Cancer

Posted 2 Aug 2016 by Drugs.com

TUESDAY, Aug. 2, 2016 – Insurance coverage and the distance to a doctor's office affect the likelihood that breast cancer patients will have reconstructive surgery after breast removal, a new study finds. Researchers analyzed data from nearly 5,400 women in North Carolina who were diagnosed with breast cancer between 2003 and 2006 and had breast removal (mastectomy) within six months of diagnosis. Twenty percent had breast reconstruction surgery within two years. Compared to patients with private insurance, those with Medicare coverage were 42 percent less likely to have breast reconstruction and those with Medicaid coverage were 76 percent less likely. Medicare and Medicaid are U.S. government health insurance programs. The University of North Carolina researchers also found that compared to women who lived within 10 miles of a plastic surgeon's office, those who lived 10 to 20 miles ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Cancer Surgeons Advise Against Removal of Healthy Breast

Posted 31 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – Only certain women with cancer in one breast should have their healthy breast removed in an attempt to prevent cancer, a leading group of breast surgeons maintains. The new position statement from the American Society of Breast Surgeons comes at a time when more breast cancer patients are asking doctors to remove the unaffected breast – a procedure known as contralateral prophylactic mastectomy. "Contralateral prophylactic mastectomy is a growing trend that has generated significant discussion among physicians, patients, breast cancer advocates and media," said position statement lead author Dr. Judy Boughey. She is professor of surgery at Mayo Clinic in Rochester, Minn. However, "it is important for patients to understand it does not improve their cancer outcome and for them to understand the pros, cons and alternatives to [contralateral prophylactic ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Palliative, Cardiothoracic Surgery

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Methadone, Hydrocodone, Percocet, Tramadol, Cancer, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Tylenol, Chronic Pain, Opana, Ibuprofen, Subutex

'Ppl, I Have Breast Cancer'

Posted 28 Jul 2016 by Drugs.com

THURSDAY, July 28, 2016 – Women who communicated via social media after a breast cancer diagnosis and received information and/or support about treatment approaches were happier with their ultimate decisions, a new study finds. Researchers surveyed thousands of women not long after they learned they had breast cancer. Those who turned to online resources – whether to share the news or gain information or support – felt more satisfied with their treatment, the study found. The researchers worry that certain breast cancer patients – especially older ones, minorities and those with lower levels of education – will miss out on the possible benefits of going online. "Our findings highlight an unmet need in patients for decisional support when they are going through breast cancer treatment," said lead study author Lauren Wallner, an assistant professor of general medicine at the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Delirium Common in Cancer Patients Seen in ER

Posted 25 Jul 2016 by Drugs.com

MONDAY, July 25, 2016 – Delirium is fairly common, yet often missed, in advanced cancer patients who visit emergency departments, a new study says. Delirium is a serious disturbance in thinking and awareness, according to the U.S. National Cancer Institute. Researchers looked for delirium in 243 advanced cancer patients seen at an emergency department. The patients were between the ages of 19 and 89. The researchers found that 22 patients – 9 percent – had delirium. Eighteen had mild delirium and four had moderate delirium. Ten percent of the 99 patients older than 65 had delirium, compared with eight percent of the 144 patients younger than 65. This suggests that advanced cancer patients of all ages should be considered at high risk for delirium, the researchers said. ER doctors failed to diagnose delirium in nine (41 percent) of the patients with delirium, the study said. The ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Melanoma - Metastatic, Breast Cancer - Palliative

Even High-Fat Mediterranean Diet Good for You: Review

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – Even a high-fat Mediterranean diet may protect against breast cancer, diabetes and heart disease, a new review finds. "If you adhere to a Mediterranean diet, you will probably have fewer heart attacks and strokes, and will be less likely to develop breast cancer and less likely to develop diabetes," said study leader Dr. Hanna Bloomfield. She is a professor of medicine at the University of Minnesota and associate chief of staff for research at the Minneapolis VA. Connie Diekman, director of university nutrition at Washington University in St. Louis, said that the findings are a good reminder that focusing on your overall dietary pattern – and not single foods or nutrients – is the key to health. "The impact of the Mediterranean diet on health has always been demonstrated to be due to the plant food pattern, and this study again appears to support that ... Read more

Related support groups: Obesity, Breast Cancer, Weight Loss, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Breast Cancer, Prevention, Breast Cancer - Palliative

'Liquid Biopsy' May Show Whether Cancer Drugs Are Working

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Researchers have developed a blood test that might allow doctors to know quickly whether a cancer drug is working. The technique is in the early stages of testing, and not ready for "prime time," scientists said. But they were also hopeful that the research will help advance the use of so-called liquid biopsies in treating cancer. Doctors have long used invasive biopsy procedures to get tumor samples, study them, then use the information to make treatment decisions or monitor a patient's response to treatment. But those procedures can be uncomfortable and carry some risks, like bleeding and infection, said Dr. Erica Mayer, a breast cancer expert with the American Society of Clinical Oncology (ASCO). Plus, she noted, some tumors are difficult to reach, and some patients are not healthy enough to have an invasive biopsy. So there's been "great interest," Mayer ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Tarceva, Breast Cancer, Prevention, Adriamycin, Breast Cancer - Palliative, Diagnosis and Investigation, Doxorubicin, Body Imaging, Adriamycin RDF, Adriamycin PFS

Innovative Trials Produce Promising Breast Cancer Drugs

Posted 9 Jul 2016 by Drugs.com

THURSDAY, July 7, 2016 – An innovative set of clinical trials have identified two drugs that could provide a fighting chance for women with advanced breast cancer. The drugs, neratinib and veliparib, both appear effective in helping women diagnosed with stage 2 or 3 breast cancer, researchers report. These are the first two drugs to come out of the I-SPY clinical trials, a research effort intended to streamline drug testing by better guiding treatments to those who would most benefit from them, said one of the study authors, Dr. Laura Esserman. She is director of breast cancer care at the University of California, San Francisco's Comprehensive Cancer Center. The results: Neratinib halted the spread of cancer in 56 percent of women with HER2-positive, hormone-receptor-negative breast cancer, compared with 33 percent of a control group receiving standard chemotherapy alone. Veliparib ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Why Breast Cancer Survivors Should Exercise

Posted 8 Jul 2016 by Drugs.com

FRIDAY, July 8, 2016 – Excessive stress can lead to memory problems among breast cancer survivors, but exercise can help, according to new research. "We found moderate to vigorous physical activity actually benefits women psychologically and that, in turn, helps their memory," said the study's lead author, Siobhan Phillips. She is assistant professor of preventive medicine at Northwestern University Feinberg School of Medicine in Chicago. Post-cancer memory issues are often attributed to chemotherapy or radiation treatments, known as "chemo brain." However, the new study findings suggest "these self-reported memory problems may be in part emotionally related," Phillips said in a university news release. "These women are frightened, stressed, fatigued, tapped out emotionally and have low self-confidence, which can be very mentally taxing and can lead to perceived memory problems," she ... Read more

Related support groups: Cancer, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Gene Tied to Breast Cancer Raises Uterine Cancer Risk Too

Posted 1 Jul 2016 by Drugs.com

THURSDAY, June 30, 2016 – Women with a gene mutation known as BRCA1 have an increased risk for a deadly form of uterine cancer, a new study finds. The BRCA1 gene mutation is already well known for significantly increasing the risk of breast and ovarian cancers. In fact, the risk is so high that some women consider having both breasts, as well as their ovaries, removed to prevent breast and ovarian cancers, the researchers noted. This latest study is the first to find a conclusive link between the mutation and a slight increase in the odds of developing an aggressive uterine cancer, the researchers said. The study authors looked at data from nearly 1,100 U.S. women with BRCA1 or BRCA2 mutations. The women were from the United States and the United Kingdom. Their health was followed for a median of about five years. BRCA2 also raises the risk of breast and ovarian cancers, according to ... Read more

Related support groups: Abnormal Uterine Bleeding, Breast Cancer, Uterine Bleeding, Ovarian Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

estradiol, testosterone, Premarin, tamoxifen, ethinyl estradiol, Estrace, fluorouracil, Zoladex, megestrol, view more... Megace, Estradiol Patch, Cenestin, Depo-Testosterone, Enjuvia, Testopel, Testopel Pellets, methyltestosterone, Menest, Android, Progynova, Megace ES, goserelin, conjugated estrogens, Delatestryl, esterified estrogens, Methitest, Thais, Tamoxifen Hexal, Adrucil, Premarin Intravenous, Testred, Delatest, Everone, Virilon IM, Estratab, Testamone-100, Testoderm, Testro AQ, Testolin, Thaissept, Depotest, Histerone, Testro, Testro-LA, FIRST-Testosterone MC, Halotestin, Meditest, Durathate 200, Andro-Cyp 100, Andro-Cyp 200, Depandro 100, Duratest, Andro LA 200, Genox, Virilon, Estinyl, Android-10, Android-25, Oreton Methyl, Soltamox, Teslac, fluoxymesterone, testolactone, Androxy, Nolvadex, Tamone, Emblon, Zumenon, Sandrena, Primogyn Depot, Oromone, Provames, Progynova TS, Valergen, Tamofen, Nolvadex D, Tamoxen, Tamosin, Systen